Schlafen 12 Is Prognostically Favorable and Reduces C-Myc and Proliferation in Lung Adenocarcinoma but Not in Lung Squamous Cell Carcinoma

SIMPLE SUMMARY: Different subtypes of lung cancer respond differently to treatment. To understand the signaling pathways that dictate the aggressive behavior of lung adenocarcinoma vs. lung squamous cell carcinoma, we performed a survival analysis that demonstrated that the protein Schlafen 12 corre...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cancers (Basel)
Asıl Yazarlar: Al-Marsoummi, Sarmad, Pacella, Jonathan, Dockter, Kaylee, Soderberg, Matthew, Singhal, Sandeep K., Vomhof-DeKrey, Emilie E., Basson, Marc D.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: MDPI 2020
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7650563/
https://ncbi.nlm.nih.gov/pubmed/32987632
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12102738
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller